CTLL-2 Cells
| Unit |
5 x 10^6 cells/ml |
|---|---|
| Cell Type |
Immortalized Cells |
| Tissue Type |
Mouse cell lines |
| Organism |
Mouse |
| Donor History | |
| Growth Properties |
Suspension |
| Growth Conditions |
Culture medium: i2Cult (We do not supply this product; please consider other suppliers. Please let us know if you need further assistance). Seeding density: 5 x 10⁵ cells/mL. Freeze medium: As a cryopreservation medium ,we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability ,or CM-1 (Cytion catalog number 800100) ,which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C ,5% CO2 ,humidified atmosphere. |
| Immortalization Method | |
| Full Information |
CTLL-2, or cytotoxic T lymphocyte cell line-2, is an immortalized mouse cell line that originates from cytotoxic T cells. These cells were obtained through repetitive allogeneic Mixed Tumor-Lymphocyte Cultures (MTLC) of spleen cells from C57BL/6 mice immunized with F4-5 Friend virus (FLV)-induced leukemia cells. This specific derivation makes CTLL-2 a highly relevant model for studying T-cell mediated responses to viral oncogenesis and tumor immunology. The cell line requires the presence of interleukin-2 (IL-2) in its culture medium for survival and proliferation, emphasizing its utility in researching cytokine-driven cell processes.
In immunological research, CTLL-2 serves as a critical tool for examining various aspects of T-cell function and cytokine biology. Its dependency on IL-2 for growth and sustenance is particularly useful for exploring the signaling pathways activated by this cytokine, as well as the broader gene expression changes in T cells responding to external stimuli. Furthermore, CTLL-2 is employed in studies related to T-cell receptor (TCR) activation, leading to insights into cell proliferation, apoptosis, and cytokine secretion. These attributes make CTLL-2 essential for high-throughput screening assays aimed at discovering new immunomodulatory agents, and for testing the biological activity of IL-2 formulations, which are pivotal in cancer immunotherapy and autoimmune disease management.
Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.
Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Třepačky
Suché lázně
Fluorometry
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Čtečky identifikačních čipů
Termočipy
Biochemie
Imunoanalýza

